Novartis outlines job losses as it steps up wholesale transformation

Nearly three months after revealing a restructuring plan, Novartis confirmed reports on Tuesday that it will reduce its global headcount by up to 8,000 people, representing more than 7% of its worldwide staff.

The cuts will come as Novartis AG (SIX:NOVN; NYSE:NVS) seeks to consolidate certain operations in its Swiss headquarters in pursuit of “a leaner and simpler” business, according to a statement shared with BioCentury...